PETMED EXPRESS INC (PETS)
$1.70+$0.10 (+6.05%) Latest session
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 8 | 356,665 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
32 Form 4 filings on record, the earliest from Oct 19, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Leslie C.G. Campbell - Officer | Grant or award | Common Stock | 60,000 | $0.00 | - | |
| James Lacamp - Director | Grant or award | Common Stock | 55,555 | $0.00 | - | |
| Peter Batushansky - Director | Grant or award | Common Stock | 55,555 | $0.00 | - | |
| Justin L. Mennen - Director | Grant or award | Common Stock | 55,555 | $0.00 | - | |
| Douglas Krulik - Officer | Grant or award | Common Stock | 32,500 | $0.00 | - | |
| Douglas Krulik - Officer | Grant or award | Performance Share Units | 32,500 | $0.00 | - | |
| Douglas Krulik - Officer | Grant or award | Common Stock | 32,500 | $0.00 | - | |
| Douglas Krulik - Officer | Grant or award | Performance Share Units | 32,500 | $0.00 | - | |
| NINA CAPITAL HOLDINGS INC. - 10% Owner | Open-market purchase | Common Stock | 25,000 | $1.75 | $44K | |
| Gian Fulgoni - Director | Derivative | Common Stock | 26,057 | $0.00 | - | |
| Gian Fulgoni - Director | Grant or award | Common Stock | 33,846 | $0.00 | - | |
| Justin L. Mennen - Director | Grant or award | Common Stock | 33,846 | $0.00 | - | |
| Peter Batushansky - Director | Grant or award | Common Stock | 33,846 | $0.00 | - | |
| Douglas Krulik - Officer | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Leah Solivan - Director | Grant or award | Common Stock | 33,846 | $0.00 | - | |
| James Lacamp - Director | Grant or award | Common Stock | 34,866 | $0.00 | - | |
| Douglas Krulik - Officer | Grant or award | Common Stock | 40,000 | $0.00 | - | |
| Douglas Krulik - Officer | Grant or award | Common Stock | 10,000 | $0.00 | - | |
| Silvercape Investments Ltd - 10% Owner | Open-market purchase | Common Stock, par value $0.001 | 101,000 | $3.17 | $320K | |
| Silvercape Investments Ltd - 10% Owner | Open-market purchase | Common Stock, par value $0.001 | 118,200 | $3.21 | $379K | |
| NINA CAPITAL HOLDINGS INC. - 10% Owner | Open-market purchase | Common Stock | 25,000 | $3.50 | $87K | |
| Silvercape Investments Ltd - 10% Owner | Open-market purchase | Common Stock, par value $0.001 | 17,565 | $3.23 | $57K | |
| Silvercape Investments Ltd - 10% Owner | Open-market purchase | Common Stock, par value $0.001 | 31,701 | $3.15 | $100K | |
| Silvercape Investments Ltd - 10% Owner | Open-market purchase | Common Stock, par value $0.001 | 2,817 | $3.22 | $9K | |
| Silvercape Investments Ltd - 10% Owner | Open-market purchase | Common Stock, par value $0.001 | 694 | $3.21 | $2K | |
| NINA CAPITAL HOLDINGS INC. - 10% Owner | Open-market purchase | Common Stock | 25,000 | $3.94 | $98K | |
| NINA CAPITAL HOLDINGS INC. - 10% Owner | Open-market purchase | Common Stock | 25,000 | $3.86 | $97K | |
| Silvercape Investments Ltd - 10% Owner | Open-market purchase | Common Stock, par value $0.001 | 7,401 | $3.95 | $29K | |
| Sandra Yvette Campos - Officer | Open-market sale | Common Stock | 58,898 | $3.31 | $195K | |
| Sandra Yvette Campos - Officer | Open-market sale | Common Stock | 1,565 | $3.33 | $5K | |
| Peter Batushansky - Director | Grant or award | Common Stock | 2,527 | $0.00 | - | |
| NINA CAPITAL HOLDINGS INC. - 10% Owner | Open-market purchase | Common Stock | 32,000 | $5.66 | $181K | |
| NINA CAPITAL HOLDINGS INC. - 10% Owner | Open-market purchase | Common Stock | 40,000 | $5.55 | $222K |
PETMED EXPRESS INC (PETS) had 6 insider filings in the last 90 days, with the most recent on 2026-08-13. The full record for PETS runs to 32 Form 4 filings, the earliest from 2024-10-19. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of PETS were filed in the last 90 days. 25 purchases are on record for this company.
No insider sales of PETS were filed in the last 90 days. 2 sales are on record for this company.
This page tracks PETS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add PETS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
